Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 71176 - 71200 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Silicon dioxide	Approved	INPP1	3628	upregulated	Silicon Dioxide analog results in increased expression of INPP1 mRNA	2q32.2	A24195
Silicon dioxide	Approved	INPP5D	3635	downregulated	Silicon Dioxide analog results in decreased expression of INPP5D mRNA	2q37.1	A24195
Silicon dioxide	Approved	INSIG1	3638	upregulated	Silicon Dioxide analog results in increased expression of INSIG1 mRNA	7q36.3	A24194
Silicon dioxide	Approved	INSIG1	3638	upregulated	Silicon Dioxide results in increased expression of INSIG1 mRNA	7q36.3	A24196
Silicon dioxide	Approved	INSIG2	51141	downregulated	Silicon Dioxide analog results in decreased expression of INSIG2 mRNA	2q14.1-q14.2	A24195
Silicon dioxide	Approved	INSL4	3641	downregulated	Silicon Dioxide analog results in decreased expression of INSL4 mRNA	9p24.1	A24195
Silicon dioxide	Approved	IP6K2	51447	upregulated	Silicon Dioxide results in increased expression of IP6K2 mRNA	3p21.31	A24196
Silicon dioxide	Approved	IPO4	79711	upregulated	Silicon Dioxide analog results in increased expression of IPO4 mRNA	14q12	A24195
Silicon dioxide	Approved	IPP	3652	downregulated	Silicon Dioxide results in decreased expression of IPP mRNA	1p34.1	A24196
Silicon dioxide	Approved	IQCE	23288	upregulated	Silicon Dioxide analog results in increased expression of IQCE mRNA	7p22.3	A24195
Silicon dioxide	Approved	IQCG	84223	downregulated	Silicon Dioxide results in decreased expression of IQCG mRNA	3q29	A24196
Silicon dioxide	Approved	IRAK1	3654	upregulated	Silicon Dioxide analog results in increased expression of IRAK1 mRNA	Xq28	A24195
Silicon dioxide	Approved	IRAK4	51135	downregulated	Silicon Dioxide analog results in decreased expression of IRAK4 mRNA	12q12	A24195
Silicon dioxide	Approved	IRAK4	51135	downregulated	Silicon Dioxide results in decreased expression of IRAK4 mRNA	12q12	A24196
Silicon dioxide	Approved	IRF1	3659	upregulated	Silicon Dioxide analog results in increased expression of IRF1 mRNA	5q31.1	A24194
Silicon dioxide	Approved	IRF1	3659	upregulated	Silicon Dioxide results in increased expression of IRF1 mRNA	5q31.1	A24196
Silicon dioxide	Approved	IRF2	3660	downregulated	Silicon Dioxide analog results in decreased expression of IRF2 mRNA	4q35.1	A24195
Silicon dioxide	Approved	IRF2BP2	359948	downregulated	Silicon Dioxide analog results in decreased expression of IRF2BP2 mRNA	1q42.3	A24195
Silicon dioxide	Approved	IRF4	3662	upregulated	Silicon Dioxide analog results in increased expression of IRF4 mRNA	6p25.3	A24194
Silicon dioxide	Approved	IRF6	3664	upregulated	Silicon Dioxide analog results in increased expression of IRF6 mRNA	1q32.2	A24194
Silicon dioxide	Approved	IRF9	10379	downregulated	Silicon Dioxide analog results in decreased expression of IRF9 mRNA	14q12	A24195
Silicon dioxide	Approved	IRF9	10379	upregulated	Silicon Dioxide results in increased expression of IRF9 mRNA	14q12	A24196
Silicon dioxide	Approved	IRS2	8660	downregulated	Silicon Dioxide analog results in decreased expression of IRS2 mRNA	13q34	A24195
Silicon dioxide	Approved	IRS2	8660	upregulated	Silicon Dioxide results in increased expression of IRS2 mRNA	13q34	A24196
Silicon dioxide	Approved	IRX2	153572	upregulated	Silicon Dioxide analog results in increased expression of IRX2 mRNA	5p15.33	A24194

Displaying entries 71176 - 71200 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability